Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2024-02-01
Product name:
SELEXID
DIN:
02456672
Product Monograph/Veterinary Labelling:
Date:
2024-02-01
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
KARO HEALTHCARE AB
Po Box 16184
Stockholm
--
Sweden
10324
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.16
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01CA08 PIVMECILLINAM
Active ingredient group (AIG) number:See footnote5
0158390002
Active ingredient(s) | Strength |
---|---|
PIVMECILLINAM HYDROCHLORIDE | 400 MG |